Health Shared Logo whiteHealth Shared Logo dark
Which people may benefit from SGLT-2 inhibitors?
Patient-Centric ManagementClinical Outcomes and Trialscoronary artery diseaseheart failurerenal failuretype 2 diabetes

Which people may benefit from SGLT-2 inhibitors?

Dr Sheharyar Quraishi, Consultant Endocrinologist and Diabetologist talks about which sorts of people would benefit from SGLT-2 inhibitors. He explains that SGLT-2 inhibitors have been shown to have benefit in people with Diabetes as well as Coronary Artery Disease or reduced Kidney Function.

Transcript (auto-generated)

This transcript was generated automatically and may contain errors.

Already, patients with, it's considered as in certain circumstances as first line or in some circumstances a second line treatment. It's a preferential treatment for patients with, as we discussed, a combination of heart failure and type 2 diabetes. It's licensed for patients who have underlying coronary artery disease and patients with renal failure, because the outcome trials suggest that there are clear benefits if patients with diabetes would have any of the other two conditions. And it's quite common to find patients who would have a combination of kidney problems and diabetes and also have coronary artery disease.

Comments


More from this author:

How often should I have Foot Checks done if I have Diabetes?